Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0001209191-21-008888

Director bought 555,555 shares at $18.00 ($9,999,990)

  • Director acquired 6,136,874 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PARMAR KUSH Director 2021-02-09 Conversion +3,308,822 3,308,822 I: show line 1 in the form
PARMAR KUSH Director 2021-02-09 Conversion +1,414,026 4,722,848 I: show line 2 in the form
PARMAR KUSH Director 2021-02-09 Purchase +111,111 $18.00 $1,999,998 4,833,959 I: show line 3 in the form
PARMAR KUSH Director 2021-02-09 Conversion +1,414,026 1,414,026 I: show line 4 in the form
PARMAR KUSH Director 2021-02-09 Purchase +444,444 $18.00 $7,999,992 1,858,470 I: show line 5 in the form
Open-market purchases · 555,555 sh · avg $18.00 · $9,999,990

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
PARMAR KUSH Director 2021-02-05 Grant or award · Stock Option (right to buy) +16,900 16,900 D: show line 6 in the form
PARMAR KUSH Director 2021-02-09 Conversion · Series A-2 Preferred Stock −45,000,000 0 I: show line 7 in the form
PARMAR KUSH Director 2021-02-09 Conversion · Series B Preferred Stock −19,230,768 0 I: show line 8 in the form
PARMAR KUSH Director 2021-02-09 Conversion · Series B Preferred Stock −19,230,768 0 I: show line 9 in the form
Loading xslF345X03/doc4.xml…